Clinical Trial: Belimumab in Myositis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Belimumab for Maintenance Therapy in Idiopathic Inflammatory Myositis

Brief Summary: The goal of the trial is to evaluate the efficacy and safety of belimumab as a maintenance therapy in adults with refractory Idiopathic inflammatory myositis (IIM) as compared with standard of care. This is a multicentre double-blind, placebo-controlled trial.